Human Cell and Tissue Product Safety
The Senate must act next: Senate consideration, where most legislation needs 60 votes to advance.
This bill passed the House with support and addresses a non-partisan safety issue, making it a strong candidate for Senate approval.
Govbase has not yet run an impact analysis on this legislation.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
The House fast-tracked this bill — limited debate, no amendments allowed, but needs two-thirds support to pass.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
The House fast-tracked this bill — limited debate, no amendments allowed, but needs two-thirds support to pass.
DEBATE - The House proceeded with forty minutes of debate on H.R. 1082.
No votes or news coverage recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Shandra Eisenga Human Cell and Tissue Product Safety Act
Analysis generated by AI. Always verify with official sources.